B BRAUN MEDICAL INC FDA Approval NDA 202106

NDA 202106

B BRAUN MEDICAL INC

FDA Drug Application

Application #202106

Documents

Letter2015-05-05
Label2015-05-06
Review2015-12-09
Summary Review2015-12-09
Label2018-01-22
Letter2018-01-26
Label2020-05-13
Letter2020-05-13
Letter2020-05-13

Application Sponsors

NDA 202106B BRAUN MEDICAL INC

Marketing Status

Prescription001
Prescription002

Application Products

001POWDER;INTRAVENOUS500MG/VIAL0MEROPENEM AND SODIUM CHLORIDE IN DUPLEX CONTAINERMEROPENEM
002POWDER;INTRAVENOUS1GM/VIAL0MEROPENEM AND SODIUM CHLORIDE IN DUPLEX CONTAINERMEROPENEM

FDA Submissions

TYPE 4; Type 4 - New CombinationORIG1AP2015-04-30STANDARD
LABELING; LabelingSUPPL3AP2018-01-19STANDARD
LABELING; LabelingSUPPL7AP2020-05-12STANDARD

Submissions Property Types

ORIG1Null15
SUPPL3Null15
SUPPL7Null6

CDER Filings

B BRAUN MEDICAL INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 202106
            [companyName] => B BRAUN MEDICAL INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"MEROPENEM AND SODIUM CHLORIDE IN DUPLEX CONTAINER","activeIngredients":"MEROPENEM","strength":"500MG\/VIAL","dosageForm":"POWDER;INTRAVENOUS","marketingStatus":"Prescription","te":"None","rld":"No","rs":"No"},{"drugName":"MEROPENEM AND SODIUM CHLORIDE IN DUPLEX CONTAINER","activeIngredients":"MEROPENEM","strength":"1GM\/VIAL","dosageForm":"POWDER;INTRAVENOUS","marketingStatus":"Prescription","te":"None","rld":"No","rs":"No"}]
            [labels] => [{"actionDate":"05\/12\/2020","submission":"SUPPL-7","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/202106s007lbl.pdf\"}]","notes":""},{"actionDate":"01\/19\/2018","submission":"SUPPL-3","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/202106s003lbl.pdf\"}]","notes":""},{"actionDate":"04\/30\/2015","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2015\\\/202106lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"04\/30\/2015","submission":"ORIG-1","actionType":"Approval","submissionClassification":"Type 4 - New Combination","reviewPriority":"STANDARD","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2015\\\/202106lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2015\\\/202106Orig1s000ltr.pdf\"},{\"name\":\"Review\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/nda\\\/2015\\\/202106Orig1s000TOC.cfm\"},{\"name\":\"Summary Review (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/nda\\\/2015\\\/202106Orig1s000SumR.pdf\"}]","notes":">"}]
            [supplements] => [{"actionDate":"05\/12\/2020","submission":"SUPPL-7","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/202106s007lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2020\\\/202106Orig1s007ltr.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2020\\\/202106Orig1s007ltr.pdf\"}]","notes":">"},{"actionDate":"01\/19\/2018","submission":"SUPPL-3","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/202106s003lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2018\\\/202106Orig1s003ltr.pdf\"}]","notes":">"},{"actionDate":"12\/15\/2015","submission":"SUPPL-1","supplementCategories":"Manufacturing (CMC)","inserts":"[]","notes":"> Please see www.fda.gov\/STIC for labeling requirements on susceptibility test interpretive criteria for systemic antibacterial and antifungal drugs. Label is not available on this site."}]
            [actionDate] => 2020-05-12
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.